Drugs / FF/VI
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04937387 | Jul 2021 → Aug 2024 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FF/VI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04937387 ↗ |
| Route | Inhaled | “FF/VI via ELLIPTA inhaler” NCT04937387 ↗ |